# Bortezomib

NDC: 72338-200
Generic name: bortezomib
Labeler / Manufacturer: Waverley Pharma Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20180619

FDA application: ANDA211898

## Active ingredients

- BORTEZOMIB: 3.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72338-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72338-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a73d7ea7-d068-4d25-b368-fc3db1898be2